Is it time to re-think the use of etravirine in patients with available genotypic resistance test?

Filippo Del Puente; Niccolo’ Riccardi; Lucia Taramasso; Alberto Borghetti; Alessandro D’Avino; Sara Irene Bonelli; Andrea De Luca; Maurizio Zazzi; Antonio Di Biagio

doi:10.1080/23744235.2019.1569257

Is it time to re-think the use of etravirine in patients with available genotypic resistance test?

Filippo Del Puente, Niccolo’ Riccardi, Lucia Taramasso, Alberto Borghetti, Alessandro D’Avino, Sara Irene Bonelli, Andrea De Luca, Maurizio Zazzi, Antonio Di Biagio

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	452-455
Journal	Infectious Diseases
Volume	51
Issue number	6
DOIs	https://doi.org/10.1080/23744235.2019.1569257
Publication status	Published - Jan 1 2019

ASJC Scopus subject areas

Immunology and Microbiology(all)
Microbiology (medical)
Infectious Diseases

Access to Document

10.1080/23744235.2019.1569257

Cite this

@article{d902541a6747442e92e273dc71c1d3ba,

title = "Is it time to re-think the use of etravirine in patients with available genotypic resistance test?",

author = "{Del Puente}, Filippo and Niccolo{\textquoteright} Riccardi and Lucia Taramasso and Alberto Borghetti and Alessandro D{\textquoteright}Avino and {Irene Bonelli}, Sara and {De Luca}, Andrea and Maurizio Zazzi and {Di Biagio}, Antonio",

year = "2019",

month = jan,

day = "1",

doi = "10.1080/23744235.2019.1569257",

language = "English",

volume = "51",

pages = "452--455",

journal = "Infectious Diseases",

issn = "2374-4235",